Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure
The Laryngoscope · 2024
DOI: 10.1002/lary.31515 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Sharon Tzelnick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontar…. Hauptthemen laut MEDLINE: Melanoma, Head and Neck Neoplasms, Lymphatic Metastasis, Neoplasm Staging. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
Stage 3 patients with clinically positive nodal metastasis are treated with therapeutic neck dissection and adjuvant systemic therapy. The aim of our study was to examined the predictability of pre‐operative CT as a nodal drainage assessment tool.
Methods
Retrospective review of all patients with clinically positive head and neck cutaneous melanoma between 2010 and 2019. Clinical disease was diagnosed as radiological suspicious, biopsy‐proven node. A pre‐operative CT evaluation for nodal metastasis was compared to pathology report.
Results
A total of 53 patients were included. Forty patients (75.5%) were males with a mean age of 59 (SD 15.52). The majority of patients (26.4%) had an unknown primary site. The most common sites for primary were the cheek in eight patients (15.1%) followed by forehead (9.4%) and lateral neck (9.4%). Preoperative CT predicted nodal disease in 84.6% of cases. The primary region that mainly failed from the previously described clinical prediction was the upper anterior neck with 83.3% parotid involvement. A total of 10 patients (18.9%) were diagnosis with non‐clinical nodes on pathology with a median non‐clinical node of 1 (range 1–2). Of them, 9 (90%) were in the same clinical levels detected by CT. Pre‐operative CT was associated with a neck level accuracy of 98.1%.
Conclusion
Stage 3 head and neck melanoma with clinically positive nodal metastasis that are eligible for an adjuvant systemic treatment, may benefit from a highly selective neck dissection according to their pre‐operative imaging studies. This should be further evaluated in a large‐scale clinical trial. Level of Evidence 3 Laryngoscope , 134:4292–4297, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
- Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Division of General Surgery, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Sharon Tzelnick
Zitieren
APA
Tzelnick, S., de Almeida, J. R., Yao, C. M. K. L., Kibel, S., Kuehne, N., Grewal, R., Butler, M. O., Saibil, S., Spreafico, A., Easson, A., & Goldstein, D. P. (2024). Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure. The Laryngoscope. https://doi.org/10.1002/lary.31515
Vancouver
Tzelnick S, de Almeida JR, Yao CMKL, Kibel S, Kuehne N, Grewal R, et al. Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure. The Laryngoscope. 2024. doi:10.1002/lary.31515
BibTeX
@article{Tzelnick2024,
author = {Tzelnick, Sharon and de Almeida, John R and Yao, Christopher M K L and Kibel, Seth and Kuehne, Nathan and Grewal, Rajan and Butler, Marcus O and Saibil, Sam and Spreafico, Anna and Easson, Alexandra and Goldstein, David P},
title = {Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31515}
}
EUVIMED